There are currently 30 active clinical trials seeking participants for Endometriosis research studies. The states with the highest number of trials for Endometriosis participants are Florida, Texas, California and Ohio.
Cannabidiol and Management of Endometriosis Pain
Recruiting
The investigators are looking to conduct a study looking at the effects of cannabidiol (CBD) in patients with endometriosis. It is believed that CBD will improve both pain and quality of life. The study will last a total of 12 weeks and involve several onsite visits in addition to daily pain assessments.
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
10/10/2023
Locations: Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania
Conditions: Endometriosis, CBD, Pelvic Pain
Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients With Endometriosis.
Recruiting
Dyspareunia is defined as pain with penetrative sexual intercourse. Women with endometriosis have a nine-fold increased risk of dyspareunia, when compared to the general female population. A prospective single-blinded randomized controlled trial will be performed evaluating the change in pelvic pain and sexual satisfaction scores from baseline to 6 weeks after treatment with transvaginal photobiomodulation therapy or sham therapy. Treatment will involve 9 planned treatment sessions over 3-4 wee... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
09/01/2023
Locations: MedStar Washington Hospital Center, Washington, District of Columbia +5 locations
Conditions: Endometriosis, Dyspareunia, Pelvic Pain
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
Recruiting
This study will test the hypothesis that the molecular changes present in ectopic endometriosis lesions correlate with progesterone-resistant disease (using the criteria defined in this study) and are present in matched eutopic endometrium.
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
08/07/2023
Locations: Yale School of Medicine, New Haven, Connecticut +2 locations
Conditions: Endometriosis, Endometrial Diseases
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Recruiting
This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.
Gender:
Female
Ages:
Between 18 years and 50 years
Trial Updated:
01/24/2023
Locations: Valley OB-GYN Clinic, PC, Saginaw, Michigan +2 locations
Conditions: Endometriosis, Diagnosis
Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (OvarestĀ®) in Women With Endometriosis
Recruiting
The pharmacodynamic endpoint of percentage of subjects with suppressed estradiol level (less than 20 pg/mL) on cycle day 29 is the primary endpoint of the study.
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
03/21/2022
Locations: Physician Care Clinical Research, LLC, Sarasota, Florida +3 locations
Conditions: Endometriosis
The EMPOWER Study: Endometriosis Diagnosis Using microRNA
Recruiting
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visi... Read More
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
01/11/2022
Locations: Stanford University Hospital, Palo Alto, California +22 locations
Conditions: Endometriosis